Vitafoods Europe 2026: Arla Foods Ingredients on high-protein concepts. Nutrition Insight (William Reed)
Again like the Ov GST1, FhGST-S1 has little conservation of the proposed prostaglandin binding residues, suggesting as with the Ov GST1, a different mode of prostaglandin binding
Conclusion Prescriptive peptide therapies, including oral BPC-157, larazotide, KPV, and injectable thymosin beta-4, offer a groundbreaking approach to managing chronic conditions like leaky gut syndrome, IBD, celiac recovery, autoimmune diseases, and MCAS
Several factors can impair B12 absorption: Reduced stomach acid production (achlorhydria or hypochlorhydria), common in older adults and those taking proton pump inhibitors or H2-receptor antagonists long-term, impairs the release of B12 from food proteins Pernicious anaemia , an autoimmune condition destroying parietal cells and reducing intrinsic factor production, completely blocks the primary absorption pathway Gastrointestinal disorders including Crohn's disease, coeliac disease, or surgical removal of stomach or ileum sections directly damage absorption sites Metformin , commonly prescribed for type 2 diabetes, may reduce B12 absorption through unclear mechanisms
BPC 157 has been studied for its effects on tendon, ligament, muscle, and bone healing